Recent Quotes
My Watchlist
Indicators
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ:VRTX)

460.87 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 973
Open 460.87
Bid (Size) 476.00 (40)
Ask (Size) 493.00 (40)
Prev. Close 460.87
Today's Range 460.87 - 460.87
52wk Range 362.50 - 519.68
Shares Outstanding 259,428,394
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Nasdaq, S&P 500 Futures Turn Green On Iran War De-Escalation Signals: Why NVDA, ORCL, JOBY, VRTX, ZVRA Are On Traders' Radar Today ↗
Data from Stocktwits indicated that retail sentiment on SPY and QQQ was stabilizing. 
Via Stocktwits
Topics Artificial Intelligence ETFs Government
News headline image
VRTX Soars In Extended Hours After Experimental Drug Shows Positive Changes In Autoimmune Kidney Disease ↗
The company said that patients treated with povetacicept achieved a 52.0% reduction from baseline in urine protein to creatinine ratio at week 36, meeting the study’s key goal. 
Via Stocktwits

Performance

YTD
+1.9%
+1.9%
1 Month
-2.1%
-2.1%
3 Month
+4.3%
+4.3%
6 Month
+16.6%
+16.6%
1 Year
-7.8%
-7.8%

More News

Read More
News headline image
Vertex Announces Positive Week 36 Interim Analysis Results for Primary and All Secondary Endpoints in the RAINIER Phase 3 Trial of Povetacicept in Adults With IgA Nephropathy
From Vertex Pharmaceuticals Incorporated
Via Business Wire
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Shows High Technical and Setup Ratings for Potential Breakout ↗
Via Chartmill
News headline image
Buying This 1 Biotech Stock Now Could Help Make You a Multimillionaire Retiree ↗
Via The Motley Fool
Topics Intellectual Property Retirement
News headline image
Vertex to Participate in Upcoming March Investor Conferences
From Vertex Pharmaceuticals Incorporated
Via Business Wire
News headline image
Vertex to Present New Data on JOURNAVX® That Demonstrates Effective Pain Management Following Aesthetic and Reconstructive Procedures
From Vertex Pharmaceuticals Incorporated
Via Business Wire
News headline image
2 Biotech Giants to Buy in 2026 ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Forget CRISPR Therapeutics: This Gene‑Editing Player Already Boasts the Profits It Dreams Of ↗
Via The Motley Fool
News headline image
Is CRISPR Therapeutics Stock Too Risky to Buy Right Now? ↗
Via The Motley Fool
News headline image
2 Top Healthcare Stocks to Buy in February ↗
Via The Motley Fool
News headline image
Forget Centessa Pharmaceuticals: This Rare‑Disease Specialist Has a Superior Portfolio and Pipeline ↗
Via The Motley Fool
News headline image
Eli Lilly Bolsters Genetic Medicine Portfolio with $2.4 Billion Acquisition of Orna Therapeutics
Via MarketMinute
Topics Intellectual Property
News headline image
2 Nasdaq 100 Stocks Worth Your Attention and 1 We Question
Via StockStory
News headline image
The Ultimate Biotech Stock to Buy With $500 Right Now ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Could Vertex Stock Help Turn $100,000 Into $1 Million by 2036? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
The Gene‑Therapy Breakthrough Story You'll Be Mad You Ignored at These Prices ↗
Via The Motley Fool
Topics ETFs
News headline image
CRISPR Therapeutics Gains After Earnings as Pipeline Hope Grows ↗
Via MarketBeat
News headline image
5 Insightful Analyst Questions From Vertex Pharmaceuticals’s Q4 Earnings Call
Via StockStory
Topics Earnings
News headline image
1 S&P 500 Stock with Competitive Advantages and 2 We Turn Down
Via StockStory
Topics Stocks
News headline image
Vertex: The Quiet Biotech Compounder I'd Happily Hold Through Any Market Crash ↗
Via The Motley Fool
Topics Artificial Intelligence Intellectual Property
News headline image
Vertex to Participate in TD Cowen 46th Annual Health Care Conference on March 3
From Vertex Pharmaceuticals Incorporated
Via Business Wire
News headline image
Moderna’s mRNA Renaissance: Navigating Volatility and the Post-Pandemic Pipeline
Via Finterra
Topics Economy Intellectual Property
News headline image
Sanofi Tightens Grip on Ocular Therapeutix with Revised Bid as Pivotal SOL-1 Trial Results Loom
Via MarketMinute
News headline image
Moderna, Vertex Pharmaceuticals, Integra LifeSciences, Baxter, and Molina Healthcare Shares Are Soaring, What You Need To Know
Via StockStory
Topics Economy

Frequently Asked Questions

Is Vertex Pharmaceuticals publicly traded?
Yes, Vertex Pharmaceuticals is publicly traded.
What exchange does Vertex Pharmaceuticals trade on?
Vertex Pharmaceuticals trades on the Nasdaq Stock Market
What is the ticker symbol for Vertex Pharmaceuticals?
The ticker symbol for Vertex Pharmaceuticals is VRTX on the Nasdaq Stock Market
What is the current price of Vertex Pharmaceuticals?
The current price of Vertex Pharmaceuticals is 460.87
When was Vertex Pharmaceuticals last traded?
The last trade of Vertex Pharmaceuticals was at 03/09/26 04:00 PM ET
What is the market capitalization of Vertex Pharmaceuticals?
The market capitalization of Vertex Pharmaceuticals is 119.56B
How many shares of Vertex Pharmaceuticals are outstanding?
Vertex Pharmaceuticals has 120B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.